B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ELAVL1

MOLECULAR TARGET

ELAV like RNA binding protein 1

UniProt: Q15717NCBI Gene: 19942 compounds

ELAVL1 (ELAV like RNA binding protein 1) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ELAVL1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1dihydrotanshinone i2.8917
2Quercetin0.691

About ELAVL1 as a Drug Target

ELAVL1 (ELAV like RNA binding protein 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented ELAVL1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ELAVL1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.